1. Home
  2. GHRS vs DEC Comparison

GHRS vs DEC Comparison

Compare GHRS & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • DEC
  • Stock Information
  • Founded
  • GHRS 2018
  • DEC 2001
  • Country
  • GHRS Ireland
  • DEC United States
  • Employees
  • GHRS N/A
  • DEC N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • DEC
  • Sector
  • GHRS Health Care
  • DEC
  • Exchange
  • GHRS Nasdaq
  • DEC Nasdaq
  • Market Cap
  • GHRS 849.8M
  • DEC 696.2M
  • IPO Year
  • GHRS 2021
  • DEC N/A
  • Fundamental
  • Price
  • GHRS $12.06
  • DEC $14.69
  • Analyst Decision
  • GHRS Strong Buy
  • DEC Strong Buy
  • Analyst Count
  • GHRS 8
  • DEC 4
  • Target Price
  • GHRS $30.63
  • DEC $20.75
  • AVG Volume (30 Days)
  • GHRS 176.0K
  • DEC 563.0K
  • Earning Date
  • GHRS 05-08-2025
  • DEC 01-01-0001
  • Dividend Yield
  • GHRS N/A
  • DEC 5.53%
  • EPS Growth
  • GHRS N/A
  • DEC N/A
  • EPS
  • GHRS N/A
  • DEC N/A
  • Revenue
  • GHRS N/A
  • DEC $758,798,000.00
  • Revenue This Year
  • GHRS N/A
  • DEC $46.42
  • Revenue Next Year
  • GHRS N/A
  • DEC $9.54
  • P/E Ratio
  • GHRS N/A
  • DEC N/A
  • Revenue Growth
  • GHRS N/A
  • DEC N/A
  • 52 Week Low
  • GHRS $6.00
  • DEC $10.08
  • 52 Week High
  • GHRS $20.50
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 52.59
  • DEC 59.45
  • Support Level
  • GHRS $11.50
  • DEC $14.65
  • Resistance Level
  • GHRS $12.94
  • DEC $15.30
  • Average True Range (ATR)
  • GHRS 0.98
  • DEC 0.45
  • MACD
  • GHRS -0.14
  • DEC -0.02
  • Stochastic Oscillator
  • GHRS 32.73
  • DEC 76.68

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: